FDA 510(k)
FDA class 2
Substantially Equivalent
🇩🇪 Germany
CardioPhase® hsCRP
K Number: K212559
·
Decision Dec 16, 2022
Classifications
1
FEI Numbers
24
Registration Numbers
24
Same Product Code
18
Applicant Total
19
Review Days
490
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- CardioPhase® hsCRP
- K Number
- K212559
- Device Class
- FDA class 2
- Clearance Type
- Special
- Regulation Number
- 866.5270
- Medical Specialty
- Immunology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Siemens Healthcare Diagnostics Products GmbH
- Date Received
- August 13, 2021
- Decision Date
- December 16, 2022
- Product Code
- NQD
- Advisory Committee
- Immunology
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NQD | Cardiac C-Reactive Protein, Antigen, Antiserum, And Control | FDA class 2 | Immunology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (NQD), ordered by most recent decision date.
Tina-quant Cardiac high sensitivity CRP III
FDA 510(k)
FDA Class 2
·Immunology
Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)
FDA 510(k)
FDA Class 2
·Immunology
CRP Vario
FDA 510(k)
FDA Class 2
·Immunology
ADVIA CHEMISTRY CARDIOPHASE HIGH SENSITIVITY C-REACTIVE PROTEIN (HSCRP), CALIBRATORS
FDA 510(k)
FDA Class 2
·Immunology
IMMAGE IMMUNOCHEMISTRY SYSTEMS HIGH SENSITIVITY CARDIAC C-REACTIVE PROTEIN (CCRP) REAGENT
FDA 510(k)
FDA Class 2
·Immunology
SYNCHRON SYSTEMS HIGH SENSITIVITY CARDIAC C-REACTIVE PROTEIN (CRPH) REAGENT
FDA 510(k)
FDA Class 2
·Immunology
Other Clearances by Siemens Healthcare Diagnostics Products GmbH
| K Number | Device Name | ||
|---|---|---|---|
| K240315 | INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban Controls (OPPS05) | Oct 10, 2024 | Substantially Equivalent |
| K233663 | N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) | Dec 13, 2023 | Substantially Equivalent |
| K220728 | vWF Ag | Jun 2, 2023 | Substantially Equivalent |
| DEN200067 | INNOVANCE VWF Ac | Sep 29, 2022 | Unknown |
| K212379 | N Latex FLC kappa, N Latex FLC lambda | Mar 2, 2022 | Substantially Equivalent |
| K201496 | N Latex FLC kappa, N Latex FLC lambda | Oct 29, 2021 | Substantially Equivalent |
| K193047 | N Latex FLC kappa, N Latex FLC lambda | Jul 14, 2021 | Substantially Equivalent |
| K190879 | N Latex FLC kappa, N Latex FLC lambda | May 3, 2019 | Substantially Equivalent |
| K182098 | N Latex FLC kappa assay, N Latex FLC lambda assay | Nov 1, 2018 | Substantially Equivalent |
| K181525 | INNOVANCE Free PS Ag | Sep 7, 2018 | Substantially Equivalent |